# High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer

> **NCT00003068** · PHASE2 · COMPLETED · sponsor: **University of Arizona** · enrollment: 30 (estimated)

## Conditions studied

- Breast Cancer
- Drug/Agent Toxicity by Tissue/Organ

## Interventions

- **DRUG:** amifostine trihydrate
- **DRUG:** cyclophosphamide
- **DRUG:** mitoxantrone hydrochloride
- **DRUG:** thiotepa
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00003068
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-06
- **Primary completion:** —
- **Final completion:** 2002-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003068, "High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00003068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*